Artykuły w czasopismach na temat „CDDOBA”
Utwórz poprawne odniesienie w stylach APA, MLA, Chicago, Harvard i wielu innych
Sprawdź 50 najlepszych artykułów w czasopismach naukowych na temat „CDDOBA”.
Przycisk „Dodaj do bibliografii” jest dostępny obok każdej pracy w bibliografii. Użyj go – a my automatycznie utworzymy odniesienie bibliograficzne do wybranej pracy w stylu cytowania, którego potrzebujesz: APA, MLA, Harvard, Chicago, Vancouver itp.
Możesz również pobrać pełny tekst publikacji naukowej w formacie „.pdf” i przeczytać adnotację do pracy online, jeśli odpowiednie parametry są dostępne w metadanych.
Przeglądaj artykuły w czasopismach z różnych dziedzin i twórz odpowiednie bibliografie.
Konopleva, Marina, Ismael Samudio, Twee Tsao, Steven M. Kornblau, Yue-Xi Shi, Teresa McQueen, Rooha Contractor i in. "Mechanisms and Activity of PPARγ-Active Triterpenoids CDDO and CDDO-Me in Leukemias." Blood 106, nr 11 (16.11.2005): 2460. http://dx.doi.org/10.1182/blood.v106.11.2460.2460.
Pełny tekst źródłaSetiawan, A. M., A. A. Syafrianno, R. Rahmat i Supari. "High-Resolution North Sulawesi Drought Hazzard Mapping Based on Consecutive Dry Days (CDD)". IOP Conference Series: Earth and Environmental Science 893, nr 1 (1.11.2021): 012018. http://dx.doi.org/10.1088/1755-1315/893/1/012018.
Pełny tekst źródłaPanwar, Kuldeep, Dinesh Prasad, Mayank Srivastava i Zainab Haseeb. "New Current Mode Lossy Integrator Employing CDDITA". Circuits and Systems 09, nr 08 (2018): 117–23. http://dx.doi.org/10.4236/cs.2018.98012.
Pełny tekst źródłaWang, Yongping, Weston W. Porter, Nanjoo Suh, Tadashi Honda, Gordon W. Gribble, Lisa M. Leesnitzer, Kelli D. Plunket i in. "A Synthetic Triterpenoid, 2-Cyano-3,12-dioxooleana-1,9-dien-28-oic Acid (CDDO), Is a Ligand for the Peroxisome Proliferator-Activated Receptor γ". Molecular Endocrinology 14, nr 10 (1.10.2000): 1550–56. http://dx.doi.org/10.1210/mend.14.10.0545.
Pełny tekst źródłaIkeda, Takashi, Yukiko Nakata, Fumihiko Kimura, Ken Sato, Kenneth Anderson, Kazuo Motoyoshi, Michael Sporn i Donald Kufe. "Induction of redox imbalance and apoptosis in multiple myeloma cells by the novel triterpenoid 2-cyano-3,12-dioxoolean-1,9-dien-28-oic acid". Molecular Cancer Therapeutics 3, nr 1 (1.01.2004): 39–45. http://dx.doi.org/10.1158/1535-7163.39.3.1.
Pełny tekst źródłaKoh, Eun-Young, Keun-Sik Kim, Hee-Bin Park, Jong-Seok Kim i Pyung-Hwan Kim. "Active Targeting of Versatile Nanocomplex Using the Novel Biomarker of Breast Cancer Stem Cells". International Journal of Molecular Sciences 24, nr 1 (30.12.2022): 685. http://dx.doi.org/10.3390/ijms24010685.
Pełny tekst źródłaKress, Christina L., Marina Konopleva, Maryla Krajewska, Vanesa Martinez-Garcia, Sophie Lefebvre, Marc L. Hyer, Teresa McQueen, Michael Andreeff, John C. Reed i Juan Zapata. "Triterpenoids Display Single Agent Activity in a Mouse Model of CLL/SBL." Blood 108, nr 11 (16.11.2006): 2530. http://dx.doi.org/10.1182/blood.v108.11.2530.2530.
Pełny tekst źródłaBrookes, Paul, Andrew Tompkins, Kimberly Morse, Shannon Hilchey, Suhail Salim, Denise Ray, Richard Phipps i Steven H. Bernstein. "The Triterpenoids 2-cyano-3,12-dioxooleana-1,9-dien-28-oic Acid (CDDO) and Their Imidazole (CDDO-Im) and Dinitrile Derivatives (DI-CDDO) Elicit Apoptosis through a Novel Mitochondrial Pathway." Blood 106, nr 11 (16.11.2005): 2426. http://dx.doi.org/10.1182/blood.v106.11.2426.2426.
Pełny tekst źródłaElsawa, Sherine F., Anne J. Novak, Marina Konopleva, Michael Andreeff, Thomas E. Witzig i Stephen M. Ansell. "Preferential Inhibition of Malignant Cell Growth by CDDO in Waldenström Macroglobulinemia." Blood 108, nr 11 (16.11.2006): 2528. http://dx.doi.org/10.1182/blood.v108.11.2528.2528.
Pełny tekst źródłaKonopleva, Marina, Twee Tsao, Peter Ruvolo, Irina Stiouf, Zeev Estrov, Clinton E. Leysath, Shourong Zhao i in. "Novel triterpenoid CDDO-Me is a potent inducer of apoptosis and differentiation in acute myelogenous leukemia". Blood 99, nr 1 (1.01.2002): 326–35. http://dx.doi.org/10.1182/blood.v99.1.326.
Pełny tekst źródłaKim, Ji-Eun, Hana Park i Tae-Cheon Kang. "CDDO-Me Distinctly Regulates Regional Specific Astroglial Responses to Status Epilepticus via ERK1/2-Nrf2, PTEN-PI3K-AKT and NFκB Signaling Pathways". Antioxidants 9, nr 10 (21.10.2020): 1026. http://dx.doi.org/10.3390/antiox9101026.
Pełny tekst źródłaChauhan, Dharminder, Guilan Li, Klaus Podar, Teru Hideshima, Reshma Shringarpure, Laurence Catley, Constantine Mitsiades i in. "The bortezomib/proteasome inhibitor PS-341 and triterpenoid CDDO-Im induce synergistic anti–multiple myeloma (MM) activity and overcome bortezomib resistance". Blood 103, nr 8 (15.04.2004): 3158–66. http://dx.doi.org/10.1182/blood-2003-08-2873.
Pełny tekst źródłaRay, Denise, Kimberly Morse, Shannon Hilchey, Tatiana Garcia, Raymond Felgar, Sanjay Maggirwar, Richard Phipps i Steven H. Bernstein. "The Novel Triterpenoid 2-cyano-3,12-dioxooleana-1,9-dien-28-oic Acid (CDDO) Induces Apoptosis of Human Diffuse Large B-Cell Lymphoma Cells (DLCL) through a Peroxisome Proliferator-Activated Receptor γ (PPARγ) Independent Pathway Which Is Enhanced by NFκB Inhibition." Blood 106, nr 11 (16.11.2005): 2425. http://dx.doi.org/10.1182/blood.v106.11.2425.2425.
Pełny tekst źródłaWelniak, Lisbeth A., Salif Harouna, David Prosser, Erik Ames, Colin Meyer i William J. Murphy. "The Antioxidant Inflammation Modulator, CDDO-Me Promotes Myelopoiesis in Mice." Blood 112, nr 11 (16.11.2008): 2335. http://dx.doi.org/10.1182/blood.v112.11.2335.2335.
Pełny tekst źródłaZapata, Juan M., Christina L. Kress, Marina Konopleva, Maryla Krajewska, Mark Hyer, Teresa McQueen i Michael Andreeff. "CDDO and CDDO-Im Reduce Tumor Burden in a Transgenic Mouse Model of CLL." Blood 104, nr 11 (16.11.2004): 3477. http://dx.doi.org/10.1182/blood.v104.11.3477.3477.
Pełny tekst źródłaChang, Chih-Hui, Hung-Pei Tsai, Shih-Hsun Kuo, Joon-Khim Loh, Chien-Ju Lin, Chih-Lung Lin i Aij-Lie Kwan. "Synthetic Triterpenoid CDDO-Me Inhibits Proliferation, Migration, and Invasion in GBM8401 and GBM8901". International Surgery 104, nr 3-4 (1.03.2020): 90–98. http://dx.doi.org/10.9738/intsurg-d-20-00005.1.
Pełny tekst źródłaKoschmieder, Steffen, Francesco D'Alò, Hanna Radomska, Christine Schöneich, Ji Suk Chang, Marina Konopleva, Susumu Kobayashi i in. "CDDO induces granulocytic differentiation of myeloid leukemic blasts through translational up-regulation of p42 CCAAT enhancer–binding protein alpha". Blood 110, nr 10 (15.11.2007): 3695–705. http://dx.doi.org/10.1182/blood-2006-11-058941.
Pełny tekst źródłaBorella, Rebecca, Luca Forti, Lara Gibellini, Anna De Gaetano, Sara De Biasi, Milena Nasi, Andrea Cossarizza i Marcello Pinti. "Synthesis and Anticancer Activity of CDDO and CDDO-Me, Two Derivatives of Natural Triterpenoids". Molecules 24, nr 22 (13.11.2019): 4097. http://dx.doi.org/10.3390/molecules24224097.
Pełny tekst źródłaKonopleva, Marina, Peter Ruvolo, Rooha Contractor, Svitlana Kurinna, Yue-Xi Shi, Teresa McQueen, Michele Milella i Michael Andreeff. "Triterpenoid Methyl-CDDO Is a Potent Inducer of Apoptosis in CD34+ AML Progenitor Cells Via Activation of SAPK Pathways and Inhibition of MAPK Cascades." Blood 104, nr 11 (16.11.2004): 2533. http://dx.doi.org/10.1182/blood.v104.11.2533.2533.
Pełny tekst źródłaKim, Min-Ju, Hana Park, Seo-Hyeon Choi, Min-Jeong Kong, Ji-Eun Kim i Tae-Cheon Kang. "CDDO-Me Attenuates Vasogenic Edema and Astroglial Death by Regulating NF-κB p65 Phosphorylations and Nrf2 Expression Following Status Epilepticus". International Journal of Molecular Sciences 20, nr 19 (30.09.2019): 4862. http://dx.doi.org/10.3390/ijms20194862.
Pełny tekst źródłaPioli, Patricia Ann, Michael S. Ball, Rajan Bhandari, Gretel Maria Torres Santiesteban, Viktor Martyanov, Mohamed Eltanbouly, Michael L. Whitfield i Karen Liby. "Redirecting Immune Activation in the Tumor Microenvironment of Estrogen Receptor Negative Breast Cancer". Journal of Immunology 204, nr 1_Supplement (1.05.2020): 242.37. http://dx.doi.org/10.4049/jimmunol.204.supp.242.37.
Pełny tekst źródłaTsai, Tai-Hsin, Cheng-Yu Tsai, Sin-Hua Moi, Chieh-Hsin Wu, Kuan-Ting Lee, Yi-Chiang Hsu i Yu-Feng Su. "A Novel Synthetic Oleanolic Acid Derivative Inhibits Glioma Cell Proliferation by Regulating Cell Cycle G2/M Arrest". Pharmaceuticals 16, nr 5 (24.04.2023): 642. http://dx.doi.org/10.3390/ph16050642.
Pełny tekst źródłaKoschmieder, Steffen, Francesco D′Alo′, Hanna Radomska, Susumu Kobayashi, Elena Levantini, Nanjoo Suh, Michael B. Sporn i in. "CDDO Increases Translation of CCAAT Enhancer Binding Protein alpha To Induce Granulocytic Differentiation." Blood 106, nr 11 (16.11.2005): 2458. http://dx.doi.org/10.1182/blood.v106.11.2458.2458.
Pełny tekst źródłaMurphy, William J., Olga Frolova, Marina Konopleva, Michael Andreeff, Weihong Ma, Danice Wilkins, Lisbeth A. Welniak i Kai Sun. "Immunomodulatory Effects of the Triterpenoid CDDO after Allogeneic Bone Marrow Transplantation in Mice: Reduction of Acute Graft-Versus-Host Disease Lethality." Blood 106, nr 11 (16.11.2005): 1316. http://dx.doi.org/10.1182/blood.v106.11.1316.1316.
Pełny tekst źródłaKurosaki, Yoshifumi, Akemi Imoto, Fumitaka Kawakami, Motoshi Ouchi, Asuka Morita, Masanori Yokoba, Tsuneo Takenaka i in. "In vitro study on effect of bardoxolone methyl on cisplatin-induced cellular senescence in human proximal tubular cells". Molecular and Cellular Biochemistry 477, nr 3 (1.01.2022): 689–99. http://dx.doi.org/10.1007/s11010-021-04295-y.
Pełny tekst źródłaSamudio, Ismael, Marina Konopleva, Numsen Hail, Yue-Xi Shi, Teresa McQueen, Timothy Hsu, Randall Evans i in. "2-Cyano-3,12-dioxooleana-1,9-dien-28-imidazolide (CDDO-Im) Directly Targets Mitochondrial Glutathione to Induce Apoptosis in Pancreatic Cancer". Journal of Biological Chemistry 280, nr 43 (23.08.2005): 36273–82. http://dx.doi.org/10.1074/jbc.m507518200.
Pełny tekst źródłaHuang, Youqun, Mulin Ye, Chunlin Wang, Zhenfen Wang i Weiping Zhou. "Protective effect of CDDO-imidazolide against intestinal ischemia/reperfusion injury in mice". European Journal of Inflammation 16 (styczeń 2018): 205873921880268. http://dx.doi.org/10.1177/2058739218802681.
Pełny tekst źródłaLiu, Caihong, i Qiang Liu. "Community Detection Based on Differential Evolution Using Modularity Density". Information 9, nr 9 (30.08.2018): 218. http://dx.doi.org/10.3390/info9090218.
Pełny tekst źródłaSamudio, Ismael, Marina Konopleva, Helene Pelicano, Peng Huang, Olga Frolova, William Bornmann, Yun-ming Ying, Randall Evans i Michael Andreeff. "A Novel Mechanism of Action of Methyl-2-cyano-3,12 dioxoolean-1,9 diene-28-oate (CDDO-Me): Direct Permeabilization of the Inner Mitochondrial Membrane To Inhibit Electron Transport and Induce Apoptosis." Blood 106, nr 11 (16.11.2005): 4462. http://dx.doi.org/10.1182/blood.v106.11.4462.4462.
Pełny tekst źródłaKim, Park, Choi, Kong i Kang. "CDDO-Me Selectively Attenuates CA1 Neuronal Death Induced by Status Epilepticus via Facilitating Mitochondrial Fission Independent of LONP1". Cells 8, nr 8 (5.08.2019): 833. http://dx.doi.org/10.3390/cells8080833.
Pełny tekst źródłaHolkova, B., S. Kummar, P. Glauber, A. Chen, J. M. Strong, R. J. Parker, J. Collins, A. J. Murgo, J. H. Doroshow i M. E. Gutierrez. "A phase I study of 2-cyano-3, 12 dioxoolean-1, 9-dien-28-oic acid (CDDO) in advance solid tumors". Journal of Clinical Oncology 25, nr 18_suppl (20.06.2007): 14137. http://dx.doi.org/10.1200/jco.2007.25.18_suppl.14137.
Pełny tekst źródłaAmeen, Azad A., Tarik A. Rashid i Shavan Askar. "CDDO–HS: Child Drawing Development Optimization–Harmony Search Algorithm". Applied Sciences 13, nr 9 (8.05.2023): 5795. http://dx.doi.org/10.3390/app13095795.
Pełny tekst źródłaGee, Min Sung, Sung-Bae Kang, Namkwon Kim, Jiyoon Choi, Nam-Jung Kim, Bum-Joon Kim, Kyung-Soo Inn i Jong Kil Lee. "Bardoxolone Methyl Suppresses Hepatitis B Virus Large Surface Protein Variant W4P-Related Carcinogenesis and Hepatocellular Carcinoma Cell Proliferation Via the Inhibition of Signal Transducer and Activator of Transcription 3 Signaling". Pharmacology 102, nr 1-2 (2018): 105–13. http://dx.doi.org/10.1159/000489998.
Pełny tekst źródłaBernstein, Steven H., Sundararajan Venkatesh, Min Li, Jae Lee, Bin Lu, Shannon P. Hilchey, Kimberly M. Morse i in. "The mitochondrial ATP-dependent Lon protease: a novel target in lymphoma death mediated by the synthetic triterpenoid CDDO and its derivatives". Blood 119, nr 14 (5.04.2012): 3321–29. http://dx.doi.org/10.1182/blood-2011-02-340075.
Pełny tekst źródłaPrasad, Dinesh, Kuldeep Panwar, D. R. Bhaskar i Mayank Srivastava. "CDDITA-Based Voltage-Mode First Order All Pass Filter Configuration". Circuits and Systems 06, nr 11 (2015): 252–56. http://dx.doi.org/10.4236/cs.2015.611025.
Pełny tekst źródłaGleixner, Karoline V., Harald Herrmann, Katharina Blatt, Winfried F. Pickl, Marina Konopleva, Gahininath Y. Bharate, Michael Andreeff, Hiroshi Maeda i Peter Valent. "The Heat Shock Protein 32 (Hsp32)/HO-1-Targeting Drug SMA-ZnPP and the Triterpenoid CDDO-Me Exert Synergistic Growth-Inhibitory Effects on TKI-Resistant Leukemic Cells in Ph+ CML". Blood 118, nr 21 (18.11.2011): 4414. http://dx.doi.org/10.1182/blood.v118.21.4414.4414.
Pełny tekst źródłaKhurana, Namrata, Partha K. Chandra, Hogyoung Kim, Asim B. Abdel-Mageed, Debasis Mondal i Suresh C. Sikka. "Bardoxolone-Methyl (CDDO-Me) Suppresses Androgen Receptor and Its Splice-Variant AR-V7 and Enhances Efficacy of Enzalutamide in Prostate Cancer Cells". Antioxidants 9, nr 1 (12.01.2020): 68. http://dx.doi.org/10.3390/antiox9010068.
Pełny tekst źródłaLin, Xun, Suzanne Tawch, Stephen Gaudino, Suyasha Roy, Patricia Castillo, Waleed Abdel Wahab Elsegeiny, Nobunao Wakabayashi i in. "Nrf2 differentially regulates pro- and anti-inflammatory function of Th17 cells through RORγT, SOD3 and Ahr". Journal of Immunology 204, nr 1_Supplement (1.05.2020): 59.34. http://dx.doi.org/10.4049/jimmunol.204.supp.59.34.
Pełny tekst źródłaBernstein, Steven H., Bin Lin, Shannon Hilchey, N. Villaluna, L. Chen, K. Madura, Kim Morse i in. "The Triterpenoid 2-Cyano-3,12-Dioxooleana-1,9-Dien-28-Oic Acid and Its Derivatives Inhibit Mitochondrial Lon Protease Activity: A Potential Novel Pathway for the Induction of Lymphoma Cell Death." Blood 114, nr 22 (20.11.2009): 414. http://dx.doi.org/10.1182/blood.v114.22.414.414.
Pełny tekst źródłaSuh, N., S. Paul, H. J. Lee, T. Yoon, N. Shah, A. I. Son, A. H. Reddi, D. Medici i M. B. Sporn. "RETRACTED: Synthetic triterpenoids, CDDO-Imidazolide and CDDO-Ethyl amide, induce chondrogenesis". Osteoarthritis and Cartilage 20, nr 5 (maj 2012): 446–50. http://dx.doi.org/10.1016/j.joca.2012.01.018.
Pełny tekst źródłaMoerland, Jess Ann, i Karen T. Liby. "Abstract 3534: The triterpenoid CDDO-Me redirects macrophage polarization and decreases tumor burden in a preclinical model of NSCLC". Cancer Research 82, nr 12_Supplement (15.06.2022): 3534. http://dx.doi.org/10.1158/1538-7445.am2022-3534.
Pełny tekst źródłaKim, Ji-Eun, Hana Park, Ji-Eun Lee i Tae-Cheon Kang. "CDDO-Me Inhibits Microglial Activation and Monocyte Infiltration by Abrogating NFκB- and p38 MAPK-Mediated Signaling Pathways Following Status Epilepticus". Cells 9, nr 5 (1.05.2020): 1123. http://dx.doi.org/10.3390/cells9051123.
Pełny tekst źródłaAmirova, Kristiana M., Petya A. Dimitrova, Milena N. Leseva, Ivanka K. Koycheva, Albena T. Dinkova-Kostova i Milen I. Georgiev. "The Triterpenoid Nrf2 Activator, CDDO-Me, Decreases Neutrophil Senescence in a Murine Model of Joint Damage". International Journal of Molecular Sciences 24, nr 10 (15.05.2023): 8775. http://dx.doi.org/10.3390/ijms24108775.
Pełny tekst źródłaSiracusa, Rosalba, Ramona D’Amico, Marika Cordaro, Alessio Filippo Peritore, Tiziana Genovese, Enrico Gugliandolo, Rosalia Crupi i in. "The Methyl Ester of 2-Cyano-3,12-Dioxooleana-1,9-Dien-28-Oic Acid Reduces Endometrial Lesions Development by Modulating the NFkB and Nrf2 Pathways". International Journal of Molecular Sciences 22, nr 8 (13.04.2021): 3991. http://dx.doi.org/10.3390/ijms22083991.
Pełny tekst źródłaPedersen, Irene M., Shinichi Kitada, Aaron Schimmer, Youngsoo Kim, Juan M. Zapata, Lula Charboneau, Laura Rassenti i in. "The triterpenoid CDDO induces apoptosis in refractory CLL B cells". Blood 100, nr 8 (15.10.2002): 2965–72. http://dx.doi.org/10.1182/blood-2002-04-1174.
Pełny tekst źródłaLin, Xun, Stephen Gaudino, Jay Kolls i Pawan Kumar. "Nrf2 selectively regulates IL-22 and IL-17A production in Th17 cells". Journal of Immunology 202, nr 1_Supplement (1.05.2019): 181.7. http://dx.doi.org/10.4049/jimmunol.202.supp.181.7.
Pełny tekst źródłaCasares, Laura, Rita Moreno, Kevin X. Ali, Maureen Higgins, Sharadha Dayalan Naidu, Graham Neill, Lena Cassin i in. "The synthetic triterpenoids CDDO-TFEA and CDDO-Me, but not CDDO, promote nuclear exclusion of BACH1 impairing its activity". Redox Biology 51 (maj 2022): 102291. http://dx.doi.org/10.1016/j.redox.2022.102291.
Pełny tekst źródłaMoerland, Jess Ann, i Karen T. Liby. "Abstract 5176: CDDO-methyl ester redirects macrophage polarization and reduces lung tumor burden in a Nrf2-dependent manner". Cancer Research 83, nr 7_Supplement (4.04.2023): 5176. http://dx.doi.org/10.1158/1538-7445.am2023-5176.
Pełny tekst źródłaKim, Ji-Eun, i Tae-Cheon Kang. "CDDO-Me Attenuates Astroglial Autophagy via Nrf2-, ERK1/2-SP1- and Src-CK2-PTEN-PI3K/AKT-Mediated Signaling Pathways in the Hippocampus of Chronic Epilepsy Rats". Antioxidants 10, nr 5 (23.04.2021): 655. http://dx.doi.org/10.3390/antiox10050655.
Pełny tekst źródłaSantiesteban, Gretel Maria Torres, Tamer Shabaneh, Rajan Bhandari, Karen Liby, Mary Jo Turk i Patricia Pioli. "CDDO-Me Redirects Macrophage Activation". Journal of Immunology 202, nr 1_Supplement (1.05.2019): 135.17. http://dx.doi.org/10.4049/jimmunol.202.supp.135.17.
Pełny tekst źródła